“I've noticed you *keep* mentioning a pullback.
Post# of 145440
![Avatar](/images/ProfileImages/573000060_60093_FD245EF6-37BD-4C88-9356-29519D0376AD.jpeg)
Because it’s inevitable. I’ve been in biotechs a long time and they always pullback, regardless of how valuable the company *should* be. I’m long CYDY, but I understand the process that’s going to take place before leronlimab realizes it’s potential, both scientifically and monetarily. And that process will include pullbacks, consolidation, etc., which is healthy.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)